- About Pancreatic Cancer
- Get Support
Caregivers
- Get Involved
- Events
- More
2024-05-01
2025-01-30
2025-03-31
250
NCT05400408
Scentech Medical Technologies Ltd
Scentech Medical Technologies Ltd
INTERVENTIONAL
Chemical Profiling of Colorectal and Pancreatic Cancers Using Breath Analysis - Feasibility Study
Detection of Colorectal and Pancreatic Cancers Using Breath Analysis - Feasibility Study
A diagnostic prospective study with no anticipated risks or constraints. Main Objective: To quantify differences in exhaled breath VOCs of patients with colorectal or pancreatic cancers compared with cohorts without cancer.
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
| Study Registration Dates | Results Reporting Dates | Study Record Updates |
|---|---|---|
2022-05-24 | N/A | 2024-02-06 |
2022-05-26 | N/A | 2024-02-07 |
2022-06-01 | N/A | 2024-02 |
This section provides details of the study plan, including how the study is designed and what the study is measuring.
Primary Purpose:
Diagnostic
Allocation:
Non Randomized
Interventional Model:
Parallel
Masking:
None
Arms and Interventions
| Participant Group/Arm | Intervention/Treatment |
|---|---|
| EXPERIMENTAL: Colorectal Cancer Subjects who were diagnosed as Colorectal Cancer patients by colonoscopy. | DIAGNOSTIC_TEST: VOX
|
| EXPERIMENTAL: Pancreatic Cancer Subjects who were diagnosed as Pancreatic Cancer patients by Endoscopic Retrograde Cholangio Pancreatography. | DIAGNOSTIC_TEST: VOX
|
| OTHER: Healthy volunteers Subjects who were found with no Colorectal or Pancreatic malignancies, by either colonoscopy or by Endoscopic Retrograde Cholangio Pancreatography. | DIAGNOSTIC_TEST: VOX
|
| Primary Outcome Measures | Measure Description | Time Frame |
|---|---|---|
| identification of Volatile Organic Compounds that can be related to Colorectal malignancy. | Comparison of identity and concentration of Volatile Organic Compounds profile found among colorectal patients and the identity and concentration of Volatile Organic Compounds profile found among Healthy controls. | Through the study completion, up to 1 year. |
| Secondary Outcome Measures | Measure Description | Time Frame |
|---|---|---|
| Test Sensitivity and specificity for colorectal polyps. | Comparison of Volatile Organic Compounds found among subjects with and without colorectal polyps. | Through the study completion, up to 1 year. |
| Test Sensitivity and specificity for pancreatic cancer. | Comparison of Volatile Organic Compounds found among pancreatic patients and Healthy controls. | Through the study completion, up to 1 year. |
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
|
Study Contact Name: HAREL HERSHTIK Phone Number: 0546641812 Email: harel.hershtik@gmail.com |
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person’s general health condition or prior treatments.
Ages Eligible for Study:
ALL
Sexes Eligible for Study:
18 Years
Accepts Healthy Volunteers:
1
This is where you will find people and organizations involved with this study.
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
No publications available
